GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes
Piaopiao Li, Zhiyan Li, Elizabeth W. Staton, Guillermo E. Umpierrez, Georgia M. Davis, Hui Shao, Francisco J. Pasquel
Abstract
This pooled cross-sectional study explores prescribing rates for glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among US patients with type 1 diabetes.
Topics & Concepts
MedicineType 2 diabetesGlucagon-like peptide 1 receptorAgonistDiabetes mellitusGlucagon-like peptide-1EndocrinologyReceptorInternal medicinePharmacologyDiabetes Treatment and ManagementDiabetes Management and ResearchPancreatic function and diabetes